A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

NCT05298254 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

NCT02030301 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes

NCT01687595 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes

NCT01154543 ·Status: COMPLETED

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

NCT05432583 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

NCT02515175 ·Status: COMPLETED ·Phase: PHASE2

Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

NCT04979975 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

HSV-2 Shedding Resolution After Acyclovir Treatment

NCT00495573 ·Status: COMPLETED

Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women

NCT02053142 ·Status: COMPLETED ·Phase: NA

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes

NCT00486200 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2

NCT04222985 ·Status: TERMINATED ·Phase: PHASE1

A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

NCT00076232 ·Status: COMPLETED ·Phase: PHASE3

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

NCT00219310 ·Status: COMPLETED ·Phase: PHASE4

A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

NCT00005663 ·Status: UNKNOWN ·Phase: PHASE3

Effect of HSV-2 Suppressive Therapy on Sexual Behavior

NCT00495716 ·Status: TERMINATED ·Phase: PHASE4

Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

NCT00002181 ·Status: COMPLETED ·Phase: NA

A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS

NCT00002116 ·Status: COMPLETED ·Phase: PHASE1

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

NCT01112956 ·Status: COMPLETED

Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant

NCT00697567 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

NCT00171990 ·Status: COMPLETED ·Phase: PHASE3

Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines

NCT00698490 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Herpes Simplex Type 1 Suppression in Hepatitis C

NCT01580995 ·Status: COMPLETED ·Phase: PHASE2

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

NCT00477334 ·Status: COMPLETED ·Phase: PHASE4

Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study

NCT05532540 ·Status: ACTIVE_NOT_RECRUITING

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

NCT01667341 ·Status: COMPLETED ·Phase: PHASE1/PHASE2